Editorial
Validating guideline concordant care in lung cancer also validates good surgical judgement and skill
Abstract
Surgical therapy with curative-intent continues to remain an important pillar in the treatment of non-small cell lung cancer (NSCLC). For thoracic surgical oncologists, integral to the long-term success of surgery for NSCLC is the preoperative identification of patients who will reap the benefits of a curative-intent treatment paradigm.